What Is the First-Line Treatment for Vasovagal Syncope?
Vasovagal syncope is a common cause of transient loss of consciousness. The primary clinical goal of first-line management is reducing how often episodes occur — decreasing the overall syncope burden for the patient.
Clinical Goal
Reduction of syncopal recurrences
Treatment Approach
First-line management for all patients centres on structured patient education and lifestyle modification — including guidance on recognising and avoiding known triggers, awareness of prodromal symptoms, and adjustments to daily habits and fluid intake.
The complete protocol also addresses individualized measures based on the patient's clinical profile, including considerations related to concurrent medications.
References
DOI: 10.1093/eurheartj/ehy037
- Explanation of the diagnosis, the provision of reassurance, and explanation of the risk of recurrence and the avoidance of triggers and situations are indicated in all patients.
- These comprise reassurance about the benign nature of the disease, education regarding awareness and the possible avoidance of triggers and situations (e.g. dehydration and/or hot crowded environments), and the early recognition of prodromal symptoms in order to sit or lie down and activate counter-pressure manoeuvres without delay.
- Increased intake of oral fluids is also advised.
- Modification or discontinuation of hypotensive drug regimen should be considered in patients with vasodepressor syncope, if possible.
- A decrease of the syncope burden is a reasonable goal of therapy.
View source ↗